DE69735644D1 - Nateglinide zubereitung in tablettenform - Google Patents

Nateglinide zubereitung in tablettenform

Info

Publication number
DE69735644D1
DE69735644D1 DE69735644T DE69735644T DE69735644D1 DE 69735644 D1 DE69735644 D1 DE 69735644D1 DE 69735644 T DE69735644 T DE 69735644T DE 69735644 T DE69735644 T DE 69735644T DE 69735644 D1 DE69735644 D1 DE 69735644D1
Authority
DE
Germany
Prior art keywords
tablet form
meals
carboxymethyl cellulose
tablet composition
nateglinide preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69735644T
Other languages
English (en)
Other versions
DE69735644T2 (de
Inventor
Akira Yabuki
Masato Kaida
Takahiko Ando
Nobutaka Ninomiya
Masanao Ozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69735644(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE69735644D1 publication Critical patent/DE69735644D1/de
Publication of DE69735644T2 publication Critical patent/DE69735644T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69735644T 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform Expired - Lifetime DE69735644T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15
JP31854196 1996-11-15
PCT/JP1997/004152 WO1998022105A1 (fr) 1996-11-15 1997-11-14 Preparation en comprimes

Publications (2)

Publication Number Publication Date
DE69735644D1 true DE69735644D1 (de) 2006-05-18
DE69735644T2 DE69735644T2 (de) 2007-05-03

Family

ID=18100283

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69740161T Expired - Lifetime DE69740161D1 (de) 1996-11-15 1997-11-14 Nateglinide-Tablettenzubereitungen
DE69735644T Expired - Lifetime DE69735644T2 (de) 1996-11-15 1997-11-14 Nateglinide zubereitung in tablettenform

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69740161T Expired - Lifetime DE69740161D1 (de) 1996-11-15 1997-11-14 Nateglinide-Tablettenzubereitungen

Country Status (14)

Country Link
US (4) US6143323A (de)
EP (3) EP1586314B1 (de)
JP (1) JP4171091B2 (de)
KR (1) KR100343062B1 (de)
CN (1) CN1245158C (de)
AT (2) ATE503472T1 (de)
AU (1) AU718350B2 (de)
CA (1) CA2271865C (de)
DE (2) DE69740161D1 (de)
DK (1) DK1586314T3 (de)
ES (2) ES2257772T3 (de)
PT (2) PT965339E (de)
TW (1) TW492878B (de)
WO (1) WO1998022105A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69740161D1 (de) 1996-11-15 2011-05-12 Ajinomoto Kk Nateglinide-Tablettenzubereitungen
US6328994B1 (en) 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
TWI257311B (en) * 1998-07-28 2006-07-01 Takeda Chemical Industries Ltd Rapidly disintegrable solid preparation
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
AR028299A1 (es) * 1999-09-17 2003-05-07 Novartis Ag Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
HUP0204109A3 (en) 1999-12-28 2004-06-28 Ajinomoto Kk Oral preparations for diabetes
AU2001241168B2 (en) * 2000-03-17 2005-06-16 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
MXPA03003484A (es) * 2000-10-18 2003-07-14 Ajinomoto Kk Procedimiento para producir cristales de nateglinida.
DE60130575T2 (de) 2000-10-18 2008-04-30 Ajinomoto Co., Inc. Verfahren zur herstellung von acylphenylalaninen
JPWO2002040010A1 (ja) * 2000-10-24 2004-06-03 味の素株式会社 ナテグリニド含有親水性医薬製剤
CN100422143C (zh) * 2000-10-24 2008-10-01 味之素株式会社 那格列奈b型结晶的制造方法
EP1334720B1 (de) * 2000-10-24 2008-09-03 Ajinomoto Co., Inc. Nateglinid enthaltende präparate
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
KR100882156B1 (ko) 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
JP5168712B2 (ja) * 2004-04-01 2013-03-27 味の素株式会社 ナテグリニド含有製剤
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
EP1776102A1 (de) * 2004-07-28 2007-04-25 Ranbaxy Laboratories Limited Präparate aus stabilen pharmazeutischen zusammensetzungen aus nateglinid und herstellungsverfahren dafür
NZ552841A (en) * 2004-08-04 2009-07-31 Alza Corp Controlled release dosage form comprising two layers, wherein the delay layer is substanially free of non-microencapsulated drug
KR20070058540A (ko) * 2004-10-01 2007-06-08 니폰 조키 세야쿠 가부시키가이샤 고형 의약제제
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
KR20070102694A (ko) * 2005-01-31 2007-10-19 아지노모토 가부시키가이샤 혈당 강하제를 함유하는, 내당능 이상, 경계형 당뇨병,인슐린 저항성 및 고인슐린혈증 개선 또는 치료용 의약조성물
KR101442862B1 (ko) * 2006-12-07 2014-09-22 다이이찌 산쿄 가부시키가이샤 만니톨 또는 유당을 함유하는 고형 제제
CA2671979C (en) 2006-12-07 2014-02-04 Daiichi Sankyo Company, Limited Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
WO2008072532A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 貯蔵安定性が改善された医薬組成物
BRPI0719529B8 (pt) * 2006-12-07 2021-05-25 Daiichi Sankyo Co Ltd método para produzir uma preparação sólida
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
ES2100291T3 (es) 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
JPH07503236A (ja) * 1991-11-26 1995-04-06 ワーナー−ランバート・コンパニー 制御放出性ジェムフィブロジル剤形の開発のための方法および組成物
DE69740161D1 (de) * 1996-11-15 2011-05-12 Ajinomoto Kk Nateglinide-Tablettenzubereitungen

Also Published As

Publication number Publication date
PT965339E (pt) 2006-06-30
US6143323A (en) 2000-11-07
PT1586314E (pt) 2011-07-01
ES2257772T3 (es) 2006-08-01
CA2271865A1 (en) 1998-05-28
EP2277517A1 (de) 2011-01-26
WO1998022105A1 (fr) 1998-05-28
DE69735644T2 (de) 2007-05-03
KR20000053312A (ko) 2000-08-25
EP0965339B1 (de) 2006-04-05
CN1242704A (zh) 2000-01-26
KR100343062B1 (ko) 2002-07-02
AU718350B2 (en) 2000-04-13
TW492878B (en) 2002-07-01
US6844008B2 (en) 2005-01-18
JPH10194969A (ja) 1998-07-28
US6641841B2 (en) 2003-11-04
EP0965339A1 (de) 1999-12-22
AU4965497A (en) 1998-06-10
CA2271865C (en) 2003-10-14
US6296872B1 (en) 2001-10-02
DK1586314T3 (da) 2011-06-20
EP1586314A1 (de) 2005-10-19
EP1586314B1 (de) 2011-03-30
US20030147951A1 (en) 2003-08-07
CN1245158C (zh) 2006-03-15
US20020028239A1 (en) 2002-03-07
EP0965339A4 (de) 2003-04-23
DE69740161D1 (de) 2011-05-12
JP4171091B2 (ja) 2008-10-22
ATE503472T1 (de) 2011-04-15
ATE322260T1 (de) 2006-04-15
ES2364145T3 (es) 2011-08-25

Similar Documents

Publication Publication Date Title
ATE322260T1 (de) Nateglinide zubereitung in tablettenform
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
BR0016801A (pt) Preparação antidiabética para administração oral
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
CO5160272A1 (es) Combinacion de cerivastatina y fibratos
IS5416A (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
EP1108429A3 (de) Verbesserte Aminosäurenzusammensetzung zum Bereitstellen von Aminosäurenergänzungen oder Eiweissersatz, insbesondere zur Behandlung und/oder Verwaltung von bestimmten Erkrankungen
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
US6683098B1 (en) Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control
JPS57139013A (en) Prophylactic or remedy for periodontosis
CA1179267A (en) Composition for relieving toothache pain
RU2053782C1 (ru) Способ лечения язвенно-некротического стоматита
KR970058708A (ko) 엘-무스콘(l-muscone)의 의약용도
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
RU94007264A (ru) Препарат для лечения ожогов кожи
KR910015294A (ko) 약제 조성물
LT2000063A (en) Food additive
TH26907A (th) องค์ประกอบทางเภสัชภัณฑ์ที่คงตัว
TH22534B (th) องค์ประกอบทางเภสัชภัณฑ์ที่คงตัว

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition